High-Throughput Drug Screening Facility, MSKCC

United States of America (USA)

1 February 2018 - 31 January 2019

No articles found. High-Throughput Drug Screening Facility, MSKCC did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Memorial Sloan Kettering Cancer Center (MSKCC)
↳ High-Throughput Drug Screening Facility, MSKCC
Adult Bone Marrow Transplant Service, MSKCC
Antitumor Assessment Core Facility, MSKCC
Bioinformatics Core Facility, MSKCC
Blood and Marrow Stem Cell Transplantation (BMT), MSKCC
Brain Tumor Center (BTC), MSKCC
Breast Cancer, MSKCC
Cell Therapy and Cell Engineering Facility, MSKCC
Center for Cell Engineering (CCE), MSKCC
Center for Epigenetics Research (CER), MSKCC
Center for Experimental Therapeutics, MSKCC
Center for Health Policy and Outcomes, MSKCC
Center for Hematologic Malignancies, MSKCC
Center for Mechanism Based Therapy, MSKCC
Center for Metastasis Research, MSKCC
Center for Molecular Imaging and Nanotechnology (CMINT), MSKCC
Center for Stem Cell Biology (CSCB), MSKCC
Center of Comparative Medicine and Pathology, MSKCC
Computational Biology Center (cBio), MSKCC
David M. Rubenstein Center for Pancreatic Cancer Research, MSKCC
Department of Chemical Biology, MSKCC
Department of Epidemiology and Biostatistics, MSKCC
Department of Laboratory Medicine, MSKCC
Department of Medical Physics, MSKCC
Clinical Genetics Service, MSKCC
Infectious Disease Service, MSKCC
Division of Hematologic Oncology, MSKCC
Division of Solid Tumor Oncology, MSKCC
Gastroenterology and Nutrition Service, MSKCC
Pulmonary Diseases, MSKCC
Department of Neurology, MSKCC
Department of Neurosurgery, MSKCC
Department of Pathology, MSKCC
Department of Pediatrics, MSKCC
Immigrant Health and Cancer Disparities Service, MSKCC
Department of Radiation Oncology, MSKCC
Molecular Imaging and Therapy Service, MSKCC
Radiochemistry and Imaging Sciences Service, MSKCC
Gynecology Service, MSKCC
Department of Urology, MSKCC
Diversity Research Programs, MSKCC
Donald B. and Catherine C. Marron Cell Metabolism Core Laboratory, MSKCC
Fiona and Stanley Druckenmiller Center for Lung Cancer Research, MSKCC
Head and Neck Service, MSKCC
Human Oncology and Pathogenesis Program (HOPP), MSKCC
Immunogenomics and Precision Oncology Platform (IPOP), MSKCC
Integrated Genomics Operation (IGO), MSKCC
Leukemia Service, MSKCC
Louis V. Gerstner Jr. Sloan Kettering Graduate School of Biomedical Sciences, MSKCC
Molecular Microbiology Core Facility (MMCF), MSKCC
Lymphoma Service, MSKCC
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, MSKCC
Memorial Hospital, MSKCC
Molecular Cytogenetics Core Facility, MSKCC
Molecular Cytology Core Facility, MSKCC
Organic Synthesis Core Facility (OSCF), MSKCC
Pathology Core Facility, MSKCC
Prostate Cancer Clinical Trials Consortium, MSKCC
Proteomics and Microchemistry Core Facility, MSKCC
Radiochemistry and Molecular Imaging Probe (RMIP) Core Facility, MSKCC
Research Engineering Laboratory (REL), MSKCC
Research Pharmacy Core Facility, MSKCC
SKI Stem Cell Research Facility, MSKCC
Sidney Kimmel Center for Prostate and Urologic Cancers, MSKCC
Cancer Biology and Genetics Program (CBG), MSKCC
Cell Biology Program, MSKCC
Chemical Biology Program, MSKCC
Computational and Systems Biology Program, MSKCC
Developmental Biology Program, MSKCC
Immunology Program, MSKCC
Molecular Biology Program, MSKCC
Molecular Pharmacology Program, MSKCC
Structural Biology Program, MSKCC

Return to institution outputs

Except where otherwise noted © 2019 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER